ClinPhone, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Nottingham United Kingdom (1993)
Status: Acquired by Parexel (2008)

Organization Overview

First Clinical Trial
2006
NCT00409539
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

aztreonam (azactam) (1 trial)

tobramycin (nebcin) (1 trial)

Drugs in Phase 2 Trials (1)

afacifenacin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 3)

Fibrosis (Phase 3)

Respiratory Aspiration (Phase 3)

Syndrome (Phase 2)

Urinary Bladder, Overactive (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3